
Company Number
11027496
Next Accounts
Dec 2025
Shareholders
the christine nhs foundation trust
Group Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
the christie nhs foundation trus, 550 wilmslow road, manchester, M20 4BX
Website
-Pomanda estimates the enterprise value of THE CHRISTIE PHARMACY LIMITED at £46.9m based on a Turnover of £77.9m and 0.6x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of THE CHRISTIE PHARMACY LIMITED at £2.2m based on an EBITDA of £503k and a 4.31x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of THE CHRISTIE PHARMACY LIMITED at £4.6m based on Net Assets of £1.9m and 2.37x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Christie Pharmacy Limited is a live company located in manchester, M20 4BX with a Companies House number of 11027496. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in October 2017, it's largest shareholder is the christine nhs foundation trust with a 100% stake. The Christie Pharmacy Limited is a young, large sized company, Pomanda has estimated its turnover at £77.9m with high growth in recent years.
Pomanda's financial health check has awarded The Christie Pharmacy Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
5 Weak
Size
annual sales of £77.9m, make it larger than the average company (£3.7m)
£77.9m - The Christie Pharmacy Limited
£3.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 15%, show it is growing at a faster rate (8.3%)
15% - The Christie Pharmacy Limited
8.3% - Industry AVG
Production
with a gross margin of 3.6%, this company has a higher cost of product (37.9%)
3.6% - The Christie Pharmacy Limited
37.9% - Industry AVG
Profitability
an operating margin of 0.7% make it less profitable than the average company (5.7%)
0.7% - The Christie Pharmacy Limited
5.7% - Industry AVG
Employees
with 53 employees, this is above the industry average (22)
53 - The Christie Pharmacy Limited
22 - Industry AVG
Pay Structure
on an average salary of £39.7k, the company has an equivalent pay structure (£46.6k)
£39.7k - The Christie Pharmacy Limited
£46.6k - Industry AVG
Efficiency
resulting in sales per employee of £1.5m, this is more efficient (£145.7k)
£1.5m - The Christie Pharmacy Limited
£145.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - The Christie Pharmacy Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 17 days, this is quicker than average (33 days)
17 days - The Christie Pharmacy Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 16 days, this is less than average (28 days)
16 days - The Christie Pharmacy Limited
28 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (26 weeks)
7 weeks - The Christie Pharmacy Limited
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 75.4%, this is a higher level of debt than the average (59%)
75.4% - The Christie Pharmacy Limited
59% - Industry AVG
The Christie Pharmacy Limited's latest turnover from March 2024 is £77.9 million and the company has net assets of £1.9 million. According to their latest financial statements, The Christie Pharmacy Limited has 53 employees and maintains cash reserves of £858 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
---|---|---|---|---|---|---|
Turnover | 77,910,000 | 65,663,000 | 56,267,000 | 51,168,000 | 38,172,000 | 42,395 |
Other Income Or Grants | 2,000 | |||||
Cost Of Sales | 75,133,000 | 63,404,000 | 54,250,000 | 49,511,000 | 36,552,000 | 40,500 |
Gross Profit | 2,779,000 | 2,259,000 | 2,017,000 | 1,657,000 | 1,620,000 | 1,895 |
Admin Expenses | 2,276,000 | 1,782,000 | 1,441,000 | 1,401,000 | 1,291,000 | 1,490 |
Operating Profit | 503,000 | 477,000 | 576,000 | 256,000 | 329,000 | 405 |
Interest Payable | 40,000 | 2,000 | 8,000 | 15,000 | 22,000 | 35 |
Interest Receivable | 2,000 | |||||
Pre-Tax Profit | 465,000 | 475,000 | 568,000 | 241,000 | 307,000 | 370 |
Tax | -116,000 | -90,000 | -107,000 | -46,000 | -59,000 | -70 |
Profit After Tax | 349,000 | 385,000 | 461,000 | 195,000 | 248,000 | 300 |
Dividends Paid | ||||||
Retained Profit | 349,000 | 385,000 | 461,000 | 195,000 | 248,000 | 300 |
Employee Costs | 2,105,000 | 1,518,000 | 1,213,000 | 1,109,000 | ||
Number Of Employees | 53 | 40 | 41 | 43 | 41 | 35 |
EBITDA* | 503,000 | 477,000 | 576,000 | 256,000 | 329,000 | 405 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
---|---|---|---|---|---|---|
Tangible Assets | ||||||
Intangible Assets | ||||||
Investments & Other | ||||||
Debtors (Due After 1 year) | ||||||
Total Fixed Assets | ||||||
Stock & work in progress | 3,329,000 | 2,677,000 | 2,196,000 | 2,438,000 | 2,387,000 | 2,009 |
Trade Debtors | 503 | |||||
Group Debtors | ||||||
Misc Debtors | 3,705,000 | 4,226,000 | 2,387,000 | 2,252,000 | 2,646,000 | 871 |
Cash | 858,000 | 458,000 | 1,296,000 | 1,315,000 | 1,165,000 | 1,529 |
misc current assets | ||||||
total current assets | 7,892,000 | 7,361,000 | 5,879,000 | 6,005,000 | 6,198,000 | 4,912 |
total assets | 7,892,000 | 7,361,000 | 5,879,000 | 6,005,000 | 6,198,000 | 4,912 |
Bank overdraft | ||||||
Bank loan | ||||||
Trade Creditors | 3,526,000 | 3,084,000 | 2,550,000 | 3,342,000 | 3,382,000 | 1,588 |
Group/Directors Accounts | 558,000 | 401,000 | 395 | |||
other short term finances | ||||||
hp & lease commitments | ||||||
other current liabilities | 1,714,000 | 2,688,000 | 2,125,000 | 1,610,000 | 1,149,000 | 1,510 |
total current liabilities | 5,798,000 | 5,772,000 | 4,675,000 | 4,952,000 | 4,932,000 | 3,493 |
loans | 156,000 | 718,000 | 1,119 | |||
hp & lease commitments | ||||||
Accruals and Deferred Income | ||||||
other liabilities | 310,000 | |||||
provisions | ||||||
total long term liabilities | 156,000 | 310,000 | 718,000 | 1,119 | ||
total liabilities | 5,954,000 | 5,772,000 | 4,675,000 | 5,262,000 | 5,650,000 | 4,612 |
net assets | 1,938,000 | 1,589,000 | 1,204,000 | 743,000 | 548,000 | 300 |
total shareholders funds | 1,938,000 | 1,589,000 | 1,204,000 | 743,000 | 548,000 | 300 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
---|---|---|---|---|---|---|
Operating Activities | ||||||
Operating Profit | 503,000 | 477,000 | 576,000 | 256,000 | 329,000 | 405 |
Depreciation | ||||||
Amortisation | ||||||
Tax | -116,000 | -90,000 | -107,000 | -46,000 | -59,000 | -70 |
Stock | 652,000 | 481,000 | -242,000 | 51,000 | 2,384,991 | 2,009 |
Debtors | -521,000 | 1,839,000 | 135,000 | -394,000 | 2,644,626 | 1,374 |
Creditors | 442,000 | 534,000 | -792,000 | -40,000 | 3,380,412 | 1,588 |
Accruals and Deferred Income | -974,000 | 563,000 | 515,000 | 461,000 | 1,147,490 | 1,510 |
Deferred Taxes & Provisions | ||||||
Cash flow from operations | -276,000 | -836,000 | 299,000 | 974,000 | -231,715 | 50 |
Investing Activities | ||||||
capital expenditure | ||||||
Change in Investments | ||||||
cash flow from investments | ||||||
Financing Activities | ||||||
Bank loans | ||||||
Group/Directors Accounts | 558,000 | -401,000 | 400,605 | 395 | ||
Other Short Term Loans | ||||||
Long term loans | 156,000 | -718,000 | 716,881 | 1,119 | ||
Hire Purchase and Lease Commitments | ||||||
other long term liabilities | -310,000 | 310,000 | ||||
share issue | ||||||
interest | -38,000 | -2,000 | -8,000 | -15,000 | -22,000 | -35 |
cash flow from financing | 676,000 | -2,000 | -318,000 | -824,000 | 1,395,186 | 1,479 |
cash and cash equivalents | ||||||
cash | 400,000 | -838,000 | -19,000 | 150,000 | 1,163,471 | 1,529 |
overdraft | ||||||
change in cash | 400,000 | -838,000 | -19,000 | 150,000 | 1,163,471 | 1,529 |
Perform a competitor analysis for the christie pharmacy limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other large companies, companies in M20 area or any other competitors across 12 key performance metrics.
THE CHRISTIE PHARMACY LIMITED group structure
The Christie Pharmacy Limited has no subsidiary companies.
Ultimate parent company
THE CHRISTIE PHARMACY LIMITED
11027496
The Christie Pharmacy Limited currently has 3 directors. The longest serving directors include Mr Paul Child (Feb 2022) and Mr Richard Postill (Oct 2022).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Paul Child | England | 59 years | Feb 2022 | - | Director |
Mr Richard Postill | United Kingdom | 50 years | Oct 2022 | - | Director |
Mr Roy Dudley-Southern | England | 78 years | Oct 2024 | - | Director |
P&L
March 2024turnover
77.9m
+19%
operating profit
503k
+5%
gross margin
3.6%
+3.68%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.9m
+0.22%
total assets
7.9m
+0.07%
cash
858k
+0.87%
net assets
Total assets minus all liabilities
company number
11027496
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
October 2017
age
8
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
GRANT THORNTON UK LLP
address
the christie nhs foundation trus, 550 wilmslow road, manchester, M20 4BX
Bank
BARCLAYS BANK PLC
Legal Advisor
BEVAN BRITTAN LLP
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the christie pharmacy limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE CHRISTIE PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|